Search - tctmd.com

Displaying 1 - 20 of 49

Sort: Relevancy | Date

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Daily News

Downsizing, Underexpansion Common in Redo TAVI With Sapien 3

Todd Neale

December 20, 2024

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Michael O'Riordan

December 02, 2024

News Conference News PCR London Valves 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2024

Shelley Wood

November 01, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

The Evolution of LAAO: Innovation Trends in Technology and Imaging

Presenter: Thomas Waggoner

October 30, 2024

Presentation TCT 2024

TCT 833: Fluoroscopic Evaluation of Post Evolut FX Implantation Commissural Alignment With Coronary Artery Ostium

Presenter: Yair Feld

October 30, 2024

Presentation TCT 2024

AS in Women

Presenter: Renuka Jain

October 29, 2024

Presentation TCT 2024

Procedural Considerations

Presenter: Kendra Grubb

October 29, 2024

Presentation TCT 2024

Case Background and Valve Selection Discussion

Presenter: Bruce Rutkin

October 29, 2024

Presentation TCT 2024

Case Outcome

Presenter: Bruce Rutkin

October 29, 2024

Presentation TCT 2024

SMART Data

Presenter: Howard Herrmann

October 29, 2024

Presentation TCT 2024

The Evolution of Transcatheter Mitral Valve Repair: Technical and Procedural Insights from an Early Human Feasibility Program (Case-Based)

Presenter: Alexandre Abizaid

October 29, 2024

Presentation TCT 2024

TCT 130: Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: LANDMARK Trial

Presenter: Pieter Smits

October 29, 2024

Presentation TCT 2024

TCT 337: Evolution of Untreated Moderate Mitral Regurgitation After Transcatheter Aortic Valve Implantation

Presenter: Massimo Baudo

October 28, 2024

Presentation TCT 2024

TCT 933: Win Ratio Analysis of LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis

Presenter: Patrick Serruys

October 28, 2024

Presentation TCT 2024

TCT 165: Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry

Presenter: Anthony Matta

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Advertisement

Top Structural Heart News of 2024

Downsizing, Underexpansion Common in Redo TAVI With Sapien 3

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

TCTMD’s Top 10 Most Popular Stories for October 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

The Evolution of LAAO: Innovation Trends in Technology and Imaging

TCT 833: Fluoroscopic Evaluation of Post Evolut FX Implantation Commissural Alignment With Coronary Artery Ostium

AS in Women

Procedural Considerations

Case Background and Valve Selection Discussion

Case Outcome

SMART Data

The Evolution of Transcatheter Mitral Valve Repair: Technical and Procedural Insights from an Early Human Feasibility Program (Case-Based)

TCT 130: Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: LANDMARK Trial

TCT 337: Evolution of Untreated Moderate Mitral Regurgitation After Transcatheter Aortic Valve Implantation

TCT 933: Win Ratio Analysis of LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis

TCT 165: Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content